Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myeloid, Acute

Explore clinical trials studying Leukemia, Myeloid, Acute. Study availability and eligibility vary by location and protocol.

2,459 public trials 541 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myeloid, Acute trial results

Recruiting

CER-1236 in Patients With Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), and Myelofibrosis (MF)

NCT06834282

Conditions
AML, Acute Myeloid Leukemia, Hematologic Diseases, +7 more
Locations
  • University of California, Davis Comprehensive Cancer Center Sacramento, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Sarah Cannon Research Insitute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

NCT04988555

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +25 more
Locations
  • Hoag Family Cancer Center Newport Beach, California, United States
  • Stanford University Palo Alto, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
View all 104 locations
View Trial Details
Recruiting

Phase IB/II of CPX-351 for Relapse Prevention in AML

NCT04990102

Conditions
Acute Myeloid Leukemia (AML) in Remission, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Recruiting

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

NCT07463651

Conditions
Acute Myeloid Leukemia (AML), Allogeneic Hematopoietic Cell Transplantation (HCT), FLT3-ITD Mutation, +10 more
Locations
  • the First Affiliated Hosptital of Soochow University Suzhou, Jiangsu, China
  • Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions